definiens: means, with respect to a molecule, that MacroGeni cs : ( a ) ( i ) owned or Controlled such molecule for any period after the Effective Date, ( ii ) previously co nducted, or is conducting, a Clinical Study with such molecule that evaluates a combination of such molecule and t he Licensed Compound, and ( iii ) has entered into, or shall ente r into, a bona fide collaboration with a Third Part y that governs the research, development and commercialization of such molecule with respect thereto ; or ( b ) has previously entered into, or enters into, a bona fide collaboration with a Third Party that go verns the research, development and/or commercialization of s uch molecule, where [COMPANY] retains development rights to sponsor and fund a Clinical Study and to provide input on the development of such molecule ; provided that in each case ( of ( a ) and ( b ) ), such T hird Party collaborator shall be contractually obli gated to the same development obligations as [COMPANY], pursua nt to Section 4.3 or otherwise in Article 4, except that in the case of ( a ), [COMPANY] shall have the final decisi on - making authority pursuant to Section 4.3(b)(i)(3 ) and Section 4.3(b)(ii )